Overview
- 3 inspections across 3 sites are on record.
- 4 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-01-09.
At a glance
Inspections
3
Sites
3
Observations
4
Career since
Jan 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| QOL Medical LLC | 9 Jan 2026 | Human Drugs | On file |
| FujiFilm Diosynth Biotechnologies U.S.A., Inc. | 10 Feb 2023 | Human Drugs | On file |
| Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 17 Jan 2019 | Human Drugs | View 483 → |
Sites inspected
QOL Medical LLCClearwater, United States1 insp.
FujiFilm Diosynth Biotechnologies U.S.A., Inc.Research Triangle Park, United States1 insp.
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCAndover, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Hirdesh Kumar1 shared
Yi Wang1 shared
Kayla V Sprague1 shared
Zhong Li1 shared
Saundrea A Munroe1 shared
Charles Y Kuo1 shared
Yuan-Chia Kuo1 shared
Sean R Marcsisin1 shared
Full investigator report
Get the verbatim findings behind Jee Y Chung's 4 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site